Table of Contents
Chemotherapy Research and Practice
Volume 2011, Article ID 965826, 9 pages
http://dx.doi.org/10.1155/2011/965826
Research Article

Development of an Oral Form of Azacytidine: 𝟐 𝟑 𝟓 Triacetyl-5-Azacytidine

1Nevada Cancer Institute, One Breakthough Way, Las Vegas, NV 89135, USA
2St. Jude Children's Research Hospital, Memphis, TN 38105, USA
3The Hong Kong Polytechnic University, Kowloon, Hong Kong

Received 12 July 2011; Revised 14 September 2011; Accepted 21 September 2011

Academic Editor: G. J. Peters

Copyright © 2011 Amy Ziemba et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Amy Ziemba, Eugene Hayes, Burgess B. Freeman III, Tao Ye, and Giuseppe Pizzorno, “Development of an Oral Form of Azacytidine: Triacetyl-5-Azacytidine,” Chemotherapy Research and Practice, vol. 2011, Article ID 965826, 9 pages, 2011. https://doi.org/10.1155/2011/965826.